Edward B Truitt, Jr

Title: The Innovations of Edward B Truitt, Jr.

Introduction

Edward B Truitt, Jr. is a notable inventor based in Kent, OH (US). He has made significant contributions to the field of medical diagnostics, particularly in the detection of chronic alcohol usage and alcoholism. His innovative approach has the potential to improve rehabilitation treatment for individuals struggling with alcohol dependency.

Latest Patents

Truitt holds a patent for the "Separation of acetaldehyde-induced hemoglobin (Hb A.sub.1-AcH)." This chromatographic method is designed to detect chronic alcohol usage and monitor alcohol rehabilitation treatment. The method enhances the resolution of the Hb A.sub.1-AcH peak from the contiguous Hb A.sub.1c peak by utilizing a polyaspartic acid chromatographic column and a nonlinear buffer gradient. The resulting Hb A.sub.1-AcH peak is evaluated to determine chronic alcohol usage, which is indicative of alcoholism and can be instrumental in monitoring rehabilitation efforts.

Career Highlights

Edward B Truitt, Jr. is affiliated with Summa Health System, where he applies his expertise in medical diagnostics. His work has been pivotal in advancing methods for assessing alcohol-related health issues, thereby contributing to better patient outcomes.

Collaborations

Truitt has collaborated with esteemed colleagues, including Susan E Hazelett and Robert A Liebelt. These partnerships have fostered a collaborative environment that enhances innovation and research in the field of medical diagnostics.

Conclusion

Edward B Truitt, Jr. exemplifies the spirit of innovation in medical technology. His contributions, particularly in the detection of chronic alcohol usage, highlight the importance of advancements in healthcare diagnostics. His work continues to impact the lives of many individuals seeking rehabilitation and recovery.